Bausch Health
BHC
#5108
Rank
โ‚น174.54 B
Marketcap
โ‚น467.36
Share price
2.73%
Change (1 day)
-23.06%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -โ‚น307.11

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -โ‚น309.03. In 2025 the company made an earnings per share (EPS) of โ‚น40.06 an increase over its 2024 EPS that were of -โ‚น11.45.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น307.11-866.64%
2025โ‚น40.06-450%
2024-โ‚น11.45-92.59%
2023-โ‚น154.52160.89%
2022-โ‚น59.23-76.64%
2021-โ‚น253.5268.45%
2020-โ‚น150.50-68.91%
2019-โ‚น484.05-57.11%
2018-โ‚น1,129-272.22%
2017โ‚น655.37-199.29%
2016-โ‚น660.03798.7%
2015-โ‚น73.44-128.31%
2014โ‚น259.43-204.62%
2013-โ‚น247.99602.7%
2012-โ‚น35.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น22.89-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น90.61-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA